| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -1 | 0.0008 |